Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wanjia Group HoldingsHKSE:00401 35 PB Ratio is 1.07 as of Aug. 21, 2026, which is 75% above its 10-year median of 0.61. GuruFocus rates HKSE:00401 with a GF Score™ of 35/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 112 Medical Distribution companies, Wanjia Group Holdings ranks better than 63.39% on this metric.
The historical rank and industry rank for Wanjia Group Holdings's PB Ratio or its related term are showing as below:
HKSE:00401'
s PB Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.61 Max: 2.74
Current: 0.87
During the past 13 years, Wanjia Group Holdings's highest PB Ratio was 2.74. The lowest was 0.26. And the median was 0.61.
HKSE:00401's PB Ratio is ranked better than 63.39% of 112
companies
in the Medical Distribution industry
Industry Median: 1.05
vs HKSE:00401: 0.87
During the past 12 months, Wanjia Group Holdings's average Book Value Per Share Growth Rate was 26.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -15.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -24.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Wanjia Group Holdings was 18.80% per year. The lowest was -43.50% per year. And the median was -24.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Wanjia Group Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wanjia Group Holdings PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Wanjia Group Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Wanjia Group Holdings (HKSE:00401) has a PB Ratio of 1.07 as of Aug. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wanjia Group Holdings and its competitors. This is 75% above median its historical median of 0.61. Over the past decade, Wanjia Group Holdings' PB Ratio has ranged from 0.26 to 2.74. According to the industry distribution chart, Wanjia Group Holdings ranks #41 out of 112 companies in the Medical Distribution industry, placing it in the top 36.6%.
Is Wanjia Group Holdings' PB Ratio too high?
Wanjia Group Holdings' current PB Ratio of 1.07 is 75% above median its 10-year median of 0.61. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 2.74. The Medical Distribution industry median PB Ratio is 1.05. Wanjia Group Holdings' value of 1.07 is 1.9% above this industry median. Based on the distribution chart, Wanjia Group Holdings ranks #41 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Wanjia Group Holdings has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wanjia Group Holdings' PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Wanjia Group Holdings ranks #41 out of 112 companies for PB Ratio. This puts Wanjia Group Holdings in the upper half of its industry. The industry median PB Ratio is 1.05. Wanjia Group Holdings' value of 1.07 is 1.9% above this benchmark. Historically, Wanjia Group Holdings' own PB Ratio has ranged from 0.26 to 2.74 over the past decade. While the company's 10-year median is 0.61 vs. the industry median of 1.05, Wanjia Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.05, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wanjia Group Holdings's current PB Ratio of 1.07 is 1.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wanjia Group Holdings and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wanjia Group Holdings's current PB Ratio is 1.07, which is 75% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wanjia Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Wanjia Group Holdings (HKSE:00401) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.13 — trading 116.7% above its estimated fair value. The current PB Ratio is 1.07, which is 75% above median its 10-year median of 0.61 and 1.9% above the Medical Distribution industry median of 1.05. Wanjia Group Holdings' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Wanjia Group Holdings (HKSE:00401), the current PB Ratio is 1.07 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wanjia Group Holdings (HKSE:00401) Overvalued in 2026?
Based on GuruFocus' analysis, Wanjia Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 116.7% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Wanjia Group Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:00401:
PB Ratio: 1.07 (75% above median its 10-year median of 0.61)
GF Value™: HK$0.06 vs. price of HK$0.13 (116.7% above fair value)
Industry Position: 1.9% above the Medical Distribution median (#41 of 112)
No single metric tells the full story. See the HKSE:00401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business. Geographically, company operates in Hong Kong and China, having majority revenue generation from Mainland China.
35GF Score
Get the complete analysis for HKSE:00401
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00401 has been successfully added to your 
